Profile
Karl Ziegelbauer is currently Chief Scientific Officer at Almirall SA since 2021.
Formerly, Dr. Ziegelbauer was SVP & Head-Open Innovation & Digital Technologies at Bayer AG and SVP, Head-Open Innovation & Digital Technologies at Bayer Pharmaceuticals from 2000 to 2019.
Dr. Ziegelbauer earned a doctorate from Eberhard Karls Universität Tübingen.
Karl Ziegelbauer active positions
| Companies | Position | Start |
|---|---|---|
| ALMIRALL, S.A. | Chief Tech/Sci/R&D Officer | 2021-07-06 |
Former positions of Karl Ziegelbauer
| Companies | Position | End |
|---|---|---|
Bayer Pharmaceuticals
Bayer Pharmaceuticals Pharmaceuticals: MajorHealth Technology Operates as a pharmaceuticals company | Corporate Officer/Principal | 2019-05-31 |
| BAYER AG | Corporate Officer/Principal | - |
Training of Karl Ziegelbauer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Almirall SA
Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Eberhard Karls Universität Tübingen
Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer Pharmaceuticals
Bayer Pharmaceuticals Pharmaceuticals: MajorHealth Technology Operates as a pharmaceuticals company | Health Technology |
- Stock Market
- Insiders
- Karl Ziegelbauer
















